Replies to post #197050 on Biotech Values

[lgonber]

Congrats, Astellas buying $OCAT for $8.50 per share, that is a 90% premium to Monday’s close. I think many on this board hold this stock. Good pick

[DewDiligence]

Astellas extends OCAT tender offer to 1/21/16:
http://www.sec.gov/Archives/edgar/data/1140098/000119312515406986/d107171dex99a1j.htm

As of last night, only 36.2% of OCAT’s shares had been tendered (http://www.sec.gov/Archives/edgar/data/1140098/000119312515407019/d107175dsc14d9a.htm ).